Biotechnica

General Summary Biotechnica is a powerful European megacorporation headquartered in Rome, Italy. Originally a small biotech firm, it rose to prominence in the early 1990s with the invention of CHOOH2, a revolutionary biofuel that reshaped global energy infrastructure. Since then, Biotechnica has become a major player in fields including biofuels, cloning, environmental restoration, pharmaceuticals, food production, and biological weapons. It has a significant global presence, operating out of countries such as Italy, the UK, France, the U.S., and Japan. Biotechnica also wields political influence and maintains significant military assets.
Key Areas of Operation 1. Biofuel Production – CHOOH2 Breakthrough: In 1991, developed CHOOH2, a grain alcohol-based biofuel made from genetically engineered yeast and wheat.
Impact: Became the global fuel standard, replacing fossil fuels in vehicles and power plants.
Licensing: Due to limited production capacity, Biotechnica licensed CHOOH2 to major corporations such as Petrochem (producing 60% of global supply), SovOil, and 14 others.
Result: Skyrocketed in value and gained megacorp status.
2. Cloning and Human Experiments Early Research: Francis Young led human cloning experiments starting in 2004.
Major Breakthrough: In 2020, Biotechnica successfully created the first self-aware human clone using construct personality technology.
Advancements: Later began attempting to implant natural digitized personalities using tech similar to the Soulkiller.
Facilities: Maintains a major R&D cloning facility in Night City with over 200 scientists and security personnel.
Ethics Violation: Secretive and unethical human testing programs such as Project Nightingale, resulting in the death of over 70 Nomads and the targeted assassinations of whistleblowers.
3. Environmental Restoration and Bioengineering Flora & Fauna: One of Biotechnica’s long-term missions is restoring ecosystems devastated by climate change.
Global Parks: Developed Lake Park in Night City and has global restoration initiatives.
Species Engineering: Created bio-engineered "replacement species" and cloned endangered/extinct animals for conservation and commercial sale.
Pacifica Confederation: Contributed major biotech advancements to aid in environmental renewal.
4. Food Production Protein Farms: Operates massive synthetic protein farms, especially around Night City’s Badlands, producing food base material for the region.
Technological Impact: Helped make the Badlands more livable via advanced agrotech.
Trade Relations: Negotiated with Nomad groups (e.g., Aldecaldos) to provide xerophyte-based reverse transpiration systems for crop development—though controversial and ultimately rejected by the clans.
5. Pharmaceuticals and Medicine Medical R&D: Active in the development of vaccines and advanced medicine, especially in response to the ongoing effects of climate change on human health.
Facilities: Labs and medical R&D centers across Europe, the U.S., and Asia.
Employee Benefits: Offers up to six days of paid vacation per year and ranks as the third-best place to work in Night City by 2077.
6. Biological Weapons Military Partnerships: Has longstanding ties with Arasaka, providing biological tech and weapons in exchange for security and protection.
War Involvement: Stayed neutral during the Fourth Corporate War, while quietly supplying both Militech and Arasaka with bio-weapons and tech.
Special Access: Provided exclusive devices to Arasaka as part of covert agreements.

Culture

Corporate Culture Known for having high-end biotech research, environmental restoration initiatives, and secure, politically advantageous partnerships.
Despite its public-facing image of eco-consciousness and scientific innovation, it has a dark underbelly involving secretive human experimentation, Nomad abuse, and corporate assassinations.
Maintains a carefully curated image as a scientific savior while engaging in morally questionable projects behind closed doors.

Assets

Resources and Equipment (as of 2020) Biotechnica maintains extensive assets, especially for transportation, research, and corporate operations:
Air Fleet:
10 × AV-4 Assault Vehicles
5 × Corporate Jets
3 × Osprey II Aircraft
1 × Boeing C-25 Heavy Cargo Jet
Facility Standards:
Each major office includes 2 helicopters and a surgery-capable infirmary.
Orbital Presence:
Owns 1 orbital research workstation for off-world experimentation and biotech development.
Political Power:
Due to its essential role in global infrastructure, Biotechnica can procure most military equipment through political influence.

History

1990s: Genesis and Global Energy Impact Founding: Biotechnica originated as a modest biotech startup in Rome, Italy, focused on industrial fermentation and genetic research.
1991 – CHOOH₂ Breakthrough: Amid a worldwide energy crisis, Biotechnica scientists engineered CHOOH₂, a yeast‑derived biofuel that fully replaced fossil fuels. Lacking production capacity, Biotechnica sold exclusive manufacturing and distribution rights to Petrochem, which came to supply 60% of global CHOOH₂ from its vast bio‑reactor farms.
Licensing Expansion: To meet demand, Biotechnica licensed CHOOH₂ production to 14 additional global partners, while retaining research royalties and sustaining megacorp status.
Strategic Alliance: Flush with capital, Biotechnica forged a symbiotic pact with Arasaka: Biotechnica supplied corporate security forces in exchange for access to Arasaka’s exclusive biological‑weapons platforms.
2000s: Covert Cloning and Ecological Ambitions 2004 – Early Human Cloning: Under lead scientist Francis Young, Biotechnica achieved illegal human‑cloning experiments. These remained covert due to international prohibition on synthetic humans.
2020 – Self‑Aware Clones: Sixteen years later, Biotechnica successfully created the first self‑aware human clone by implanting an artificial construct personality. Parallel R&D pursued natural personality transfer via “Soulkiller‑style” biochips. The Night City cloning facility—staffed by ~200 scientists and security—became the epicenter of this sensitive work.
Environmental Restoration: Driven by the climate‑crisis impact on flora and fauna, Biotechnica established global restoration labs. In the early 2020s, it opened Lake Park in Night City and initiated wildlife‑cloning programs to reintroduce endangered species—both conservation and high‑margin commercial ventures.
2022: Neutrality in the Fourth Corporate War Corporate Stance: During the Militech–Arasaka Fourth Corporate War, Biotechnica maintained formal neutrality.
Dual‑Supplier Role: It discreetly supplied both sides with advanced biological agents, vaccines, and R&D support—though its longstanding Arasaka alliance secured Arasaka’s exclusive access to certain cutting‑edge devices.
2070s: Bioengineering a New World Global Ecological Projects: By 2077, Biotechnica led massive reforestation, wetland restoration, and species‑revival initiatives, leveraging synthetic biology to rebuild damaged ecosystems.
Protein Farms: In the Badlands south of Night City, Biotechnica’s tent‑like protein farms produce synthetic protein at scale, underpinning the city’s primary food supply. Similar farms operate worldwide.
Healthcare & Vaccines: Amid accelerating climate‑driven disease threats, Biotechnica’s vaccine R&D became critical—developing next‑generation immunotherapies and climate‑resilient pharmaceuticals.
Workplace Reputation: Offering up to six paid vacation days annually, Biotechnica was rated the third‑best employer in Night City by 2077.
Key Controversies and Human Cost Project Nightingale (2075): Under Dr. Joanne Koch, Biotechnica covertly abducted members of the Red Ocher nomad clan for neural‑interface experiments. Seventy nomads died. To cover up the scandal, Koch ordered the assassination of colleague Emilia Morton and investigative journalist Manuel Mendoza.
Failed Nomad Partnership: In 2077, nomad leader Saul Bright attempted to negotiate clan employment in Biotechnica’s Badlands farms in exchange for agricultural technology; internal opposition scuttled the deal.
Legacy and Strategic Position From pioneering the world’s first yeast‑based biofuel to breaking ethical boundaries in human cloning and mass‑environmental engineering, Biotechnica’s history is marked by transformative innovation, clandestine ambition, and controversial human‑rights violations. Its dual role—as savior of ecosystems and architect of bioweapons—cements its complex legacy in Night City and beyond.

"Adapting You to the Future" "We make the world move

Type

Corporation, Medical